Search research articles
Contact Us
Filters
Showing results (171-180 of 216) with videos related to
Page
of 22
Sort By:
Bioconjugate Chemistry
|
May 6, 2014
Bridging disulfides for stable and defined antibody drug conjugates
George Badescu, Penny Bryant, Matthew Bird, et al.
AIDS (London, England)
|
June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures
Andrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 1, 2010
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study
Frank A Post, Graeme J Moyle, Hans Jürgen Stellbrink, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 22, 2010
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
Thomas P Matthews, Tatiana McHardy, Suki Klair, et al.
Plos Pathogens
|
July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Plos One
|
June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006
Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
International Journal of STD & AIDS
|
January 2, 2016
UK national guidelines on the management of syphilis 2015
M Kingston, P French, S Higgins, et al.
JAMA Network Open
|
December 12, 2022
Effect of a Multisectoral Agricultural Intervention on HIV Health Outcomes Among Adults in Kenya: A Cluster Randomized Clinical Trial
Craig R Cohen, Elly Weke, Edward A Frongillo, et al.
AIDS (London, England)
|
September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study
, Katherine J Lee, David Dunn, et al.
AIDS (London, England)
|
August 11, 2007
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count
Andrew N Phillips, Brian Gazzard, Richard Gilson, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 216) with videos related to
Sort By:
Page
of 22
Bioconjugate Chemistry
|
May 6, 2014
Bridging disulfides for stable and defined antibody drug conjugates
George Badescu, Penny Bryant, Matthew Bird, et al.
AIDS (London, England)
|
June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures
Andrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 1, 2010
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study
Frank A Post, Graeme J Moyle, Hans Jürgen Stellbrink, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 22, 2010
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
Thomas P Matthews, Tatiana McHardy, Suki Klair, et al.
Plos Pathogens
|
July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Plos One
|
June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006
Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
International Journal of STD & AIDS
|
January 2, 2016
UK national guidelines on the management of syphilis 2015
M Kingston, P French, S Higgins, et al.
JAMA Network Open
|
December 12, 2022
Effect of a Multisectoral Agricultural Intervention on HIV Health Outcomes Among Adults in Kenya: A Cluster Randomized Clinical Trial
Craig R Cohen, Elly Weke, Edward A Frongillo, et al.
AIDS (London, England)
|
September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study
, Katherine J Lee, David Dunn, et al.
AIDS (London, England)
|
August 11, 2007
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count
Andrew N Phillips, Brian Gazzard, Richard Gilson, et al.
Page
of 22